News

Replication of the omicron variant of SARS-CoV-2 within cells is drastically lower than previous variants, perhaps as a result of the virus mutating to escape the immune response.

According to a study, a newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable and scalable.

An experimental drug called ION363 is being investigated in ALS patients in a global, Phase 3 clinical trial taking place in the United States, Europe and Asia.

Scientists have found more than 1,000 gene-activation differences between female and male mice’s brains, plus more than 600 between females in different stages of their reproductive cycle.

Researchers have identified the highly prevalent, specific mutations that are causing the Omicron variant’s high rate of infection.

Researchers have developed the first Fish Flow map on the Island of Hawai‘i, allowing the entire life cycle of ocean fishes to be studied.

Exercise in later life may reduce the epigenetic aging of cells by around 10%.

Scientists at the University of Bristol have developed new biological parts that are able to shape the flow of cellular processes along DNA.

Lactic acid is abundant in cancer cells and may end up as epigenetic marks. Enzymes capable of removing lactic acid marks have been identified and may help advance cancer treatment.

The first peer-reviewed research outlining the successful transplant of genetically modified, clinical-grade pig kidneys into a brain-dead human individual, replacing the recipient’s native kidneys, has been announced.